Lisa Kelly-Croswell - Jul 18, 2022 Form 3 Insider Report for Eiger BioPharmaceuticals, Inc. (EIGR)

Role
Director
Signature
/s/ Sriram Ryali, Attorney-in-Fact
Stock symbol
EIGR
Transactions as of
Jul 18, 2022
Transactions value $
$0
Form type
3
Date filed
7/19/2022, 06:58 PM
Previous filing
Jun 13, 2022
Next filing
Mar 3, 2023

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney